Compare Sanofi India with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs IPCA LABS - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA IPCA LABS SANOFI INDIA/
IPCA LABS
 
P/E (TTM) x 39.5 24.1 163.7% View Chart
P/BV x 8.0 8.6 93.1% View Chart
Dividend Yield % 1.1 0.1 771.8%  

Financials

 SANOFI INDIA   IPCA LABS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
IPCA LABS
Mar-19
SANOFI INDIA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs6,8401,042 656.4%   
Low Rs4,630590 784.6%   
Sales per share (Unadj.) Rs1,203.1298.6 402.9%  
Earnings per share (Unadj.) Rs165.335.0 472.2%  
Cash flow per share (Unadj.) Rs209.949.4 424.5%  
Dividends per share (Unadj.) Rs84.003.00 2,800.0%  
Dividend yield (eoy) %1.50.4 398.4%  
Book value per share (Unadj.) Rs963.6247.1 389.9%  
Shares outstanding (eoy) m23.03126.35 18.2%   
Bonus/Rights/Conversions -ESOS-  
Price / Sales ratio x4.82.7 174.4%   
Avg P/E ratio x34.723.3 148.8%  
P/CF ratio (eoy) x27.316.5 165.6%  
Price / Book Value ratio x6.03.3 180.2%  
Dividend payout %50.88.6 593.0%   
Avg Mkt Cap Rs m132,078103,108 128.1%   
No. of employees `0003.313.4 24.6%   
Total wages/salary Rs m4,0687,874 51.7%   
Avg. sales/employee Rs Th8,393.82,807.0 299.0%   
Avg. wages/employee Rs Th1,232.4585.8 210.4%   
Avg. net profit/employee Rs Th1,153.0329.0 350.5%   
INCOME DATA
Net Sales Rs m27,70837,732 73.4%  
Other income Rs m897577 155.5%   
Total revenues Rs m28,60538,309 74.7%   
Gross profit Rs m6,2356,901 90.4%  
Depreciation Rs m1,0271,824 56.3%   
Interest Rs m7189 3.7%   
Profit before tax Rs m6,0985,465 111.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2921,042 219.9%   
Profit after tax Rs m3,8064,422 86.1%  
Gross profit margin %22.518.3 123.0%  
Effective tax rate %37.619.1 197.0%   
Net profit margin %13.711.7 117.2%  
BALANCE SHEET DATA
Current assets Rs m15,92223,778 67.0%   
Current liabilities Rs m6,23510,975 56.8%   
Net working cap to sales %35.033.9 103.0%  
Current ratio x2.62.2 117.9%  
Inventory Days Days64104 61.3%  
Debtors Days Days2166 31.7%  
Net fixed assets Rs m7,53920,368 37.0%   
Share capital Rs m230253 91.0%   
"Free" reserves Rs m21,96230,971 70.9%   
Net worth Rs m22,19231,224 71.1%   
Long term debt Rs m01,409 0.0%   
Total assets Rs m29,83945,507 65.6%  
Interest coverage x872.130.0 2,911.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.8 112.0%   
Return on assets %12.810.1 126.1%  
Return on equity %17.214.2 121.1%  
Return on capital %27.517.3 158.8%  
Exports to sales %045.9 0.0%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs mNA17,308 0.0%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m7,58717,308 43.8%   
Fx outflow Rs m7,1456,266 114.0%   
Net fx Rs m44211,042 4.0%   
CASH FLOW
From Operations Rs m3,7394,923 76.0%  
From Investments Rs m-731-1,563 46.8%  
From Financial Activity Rs m-1,972-1,832 107.6%  
Net Cashflow Rs m1,0361,528 67.8%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 11.4 126.3%  
FIIs % 14.6 25.3 57.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 17.4 60.3%  
Shareholders   15,184 36,892 41.2%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DR. DATSONS LABS  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT PHARMOVA   DIVIS LABORATORIES  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 12, 2021 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS